A new advisory forum under the EU’s health emergency preparedness authority, HERA, is opening the doors for industry players to have a voice in the union’s future health crisis management. The proposal is a step in the right direction, say one industry association and Bavarian Nordic.
Roche and Novartis have been behind almost 10 percent of all application submissions to the Danish Medicines Council since 2017. In a column, representatives from both firms point out three problems and make concrete proposals for how to improve the council’s work.
Seven women at the top of the Danish life science industry want to secure diversity in the sector, and have formed a network to help other women climb the career ladder. Boards lacking diversity are at a disadvantage, says Julia Brooker, country director Denmark at Janssen.